← Leaderboards
Christopher Andrew Henderson
University Of Virginia
$166,926
Attributed
$166,926
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51K · FY2019–22$100K$75K$50K$25K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$166,926 · 1
By mechanism
F30$166,926 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia
Same institution · by research overlap
- Gary K Owens$62,453,400
- Angela M Taylor$3,600,158
- Craig H Meyer$4,645,866
- Sayo Erick McCowin$171,035
- Brett Ransegnola$76,960
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAffinityAlanineAllelesAlpha ActinAmino AcidsAmino Acid SubstitutionAnimal ModelApolipoprotein EArterial Fatty StreakArterial LesionAtherosclerosisAttenuatedBaseBhlh ProteinBindingBiologyBurden Of IllnessCardiovascular DiseasesCardiovascular Disorder RiskCardiovascular PathologyCardiovascular SystemCarotid Intima-Media ThicknessAblation
Grant awards (4)
From genotype to phenotype: Molecular and functional characterization of the ID3 SNP rs11574 in CVD$48,464
F30 · FY2022 · HL · contact PI
From genotype to phenotype: Molecular and functional characterization of the ID3 SNP rs11574 in CVD$51,036
F30 · FY2021 · HL · contact PI
From genotype to phenotype: Molecular and functional characterization of the ID3 SNP rs11574 in CVD$33,965
F30 · FY2020 · HL · contact PI
From genotype to phenotype: Molecular and functional characterization of the ID3 SNP rs11574 in CVD$33,461
F30 · FY2019 · HL · contact PI